Search Results
10
Everything
Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data
March 28, 2025 08:30 ET
|
Silexion Therapeutics Corp
Grand Cayman, Cayman Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA...
Asia-Pacific Genome Sequencing Research Report 2025: A $5.96 Billion Market by 2033 - Opportunities in Emergence of Portable Genome Sequencing Enabling Bedside Testing and Multiomics
March 26, 2025 07:57 ET
|
Research and Markets
Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast, 2024-2033" report has been added to ...
Registration Now Open: Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) Conference 2025 (Miami, FLORIDA, United States - May 15-16, 2025)
March 25, 2025 05:30 ET
|
Research and Markets
Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2025" conference has been added to ResearchAndMarkets.com's offering. The...
Cross-Border University Collaboration Will Expand Research to Advance Precision Medicine
March 24, 2025 10:00 ET
|
Tecnológico de Monterrey
Tec de Monterrey and UT Austin launch OriGen Health to advance precision medicine and Latino health using AI, genetics, and Latin America’s largest biobank
Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
March 21, 2025 16:30 ET
|
Baylor Genetics
HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory celebrating a decade at the forefront of genetic testing, today shared research on the value of both...
Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204 which will be unveiled at the 2025 NeauxCancer Conference
March 21, 2025 08:30 ET
|
Silexion Therapeutics Corp
Grand Cayman, Cayman Islands, March 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi)...
InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
March 19, 2025 09:26 ET
|
InformedDNA
The combined company will expand patient, provider and payor access to genetic insights to personalize care, improve patient outcomes and reduce costs.
Silexion Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 18, 2025 16:29 ET
|
Silexion Therapeutics Corp
Grand Cayman, Cayman Islands, March 18, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA...
Circulating DNA RNA Patent Landscape Report and Forecast 2024-2032: Nantomics, Genentech, and Novartis are Pivotal in the Development of the $16.4 Billion Market
March 14, 2025 12:24 ET
|
Research and Markets
Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Circulating DNA RNA Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. A newly revealed...
MSInsight annonce une levée de fonds d’amorçage de 1,6 M€ pour révolutionner le diagnostic des cancers MSI
March 10, 2025 12:45 ET
|
MSInsight
Communiqué de presse Paris, le 12 mars 2025 – MSInsight, start-up innovante spécialisée dans la médecine de précision en oncologie, annonce la réussite de son tour de financement d’amorçage d'un...